Zhang, Xiaoyang
Meyerson, Matthew http://orcid.org/0000-0002-9133-8108
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R00CA215244, R35CA197568)
Article History
Received: 21 October 2019
Accepted: 13 August 2020
First Online: 14 September 2020
Competing interests
: M.M. receives commercial research grants from Bayer, Novo Ventures, Ono and Janssen; receives royalties from LabCorp; and serves as a consultant and advisory board member for OrigiMed.